Kouklis P D, Merdes A, Papamarcaki T, Georgatos S D
Cell Biology Programme, European Molecular Biology Laboratory, Heidelberg/Germany.
Eur J Cell Biol. 1993 Dec;62(2):224-36.
We have microinjected anti-vimentin antibodies into nocodazole-arrested, prometaphasic 3T3 cells. Exit of injected and control cells from mitosis has been assessed at various time points after release from nocodazole by examining the distribution of nuclear lamins, the degree of chromatin condensation and the appearance of daughter cells. It is shown here that 1 h after release from nocodazole, the vast majority of cells injected with control antibodies enter interphase, whereas most of the cells injected with antivimentin antibodies remain prometaphasic. Microinjection of vimentin-free (MCF-7) cells with anti-vimentin antibodies does not affect the normal completion of mitosis in the majority of the cells. The arresting effect on 3T3 cells is dependent on the concentration of the microinjected anti-vimentin antibodies and can also be detected when Fabs are injected instead of intact IgG. Sampling at later time points and monitoring of individual microinjected cells indicate that the antibody-induced effect lasts for 1.5 to 4 h, i.e., up to 400% longer than the normal mitotic cycle of 3T3 cells. However, 4 h after release from nocodazole, most of the antibody-arrested cells recover and divide successfully. Electron microscopy shows that the IFs of the microinjected cells are thicker than normal and tend to anastomose. Interestingly, the nuclei of some of the cells that escape the antibody-induced arrest and successfully divide appear segmented or lobulated. Using a mitotic cell-free system, we further demonstrate that anti-vimentin antibodies interfere with nuclear lamin assembly around chromatin particles. In agreement to the in vivo results, the inhibitory effect of the antibodies appears to subside with time. Taken together, these data suggest that the remodelling of the vimentin network which normally takes place during mitosis is an important rearrangement of the cytoplasm required for efficient nuclear reassembly at the end of cell division.
我们已将抗波形蛋白抗体显微注射到用诺考达唑阻滞的、处于前中期的3T3细胞中。通过检查核纤层蛋白的分布、染色质凝聚程度以及子细胞的外观,在从诺考达唑释放后的不同时间点评估了注射抗体的细胞和对照细胞从有丝分裂中退出的情况。结果显示,从诺考达唑释放1小时后,注射对照抗体的绝大多数细胞进入间期,而注射抗波形蛋白抗体的大多数细胞仍处于前中期。用抗波形蛋白抗体对无波形蛋白(MCF - 7)细胞进行显微注射,大多数细胞的有丝分裂正常完成不受影响。对3T3细胞的阻滞作用取决于显微注射的抗波形蛋白抗体的浓度,当注射Fabs而非完整IgG时也能检测到这种阻滞作用。在后续时间点取样并监测单个显微注射细胞表明,抗体诱导的效应持续1.5至4小时,即比3T3细胞正常有丝分裂周期长400%。然而,从诺考达唑释放4小时后,大多数被抗体阻滞的细胞恢复并成功分裂。电子显微镜显示,显微注射细胞的中间丝比正常的粗且倾向于相互吻合。有趣的是,一些逃脱抗体诱导阻滞并成功分裂的细胞的细胞核呈现出分段或分叶状。使用无细胞有丝分裂系统,我们进一步证明抗波形蛋白抗体干扰染色质颗粒周围的核纤层蛋白组装。与体内结果一致,抗体的抑制作用似乎随时间减弱。综上所述这些数据表明,通常在有丝分裂期间发生的波形蛋白网络重塑是细胞分裂末期高效核重新组装所需的细胞质重要重排。